De Bruyn W, Herrlinger A, Sigel A
Urologische klinik, Universität Erlangen-Nürnberg, RFA.
J Urol (Paris). 1989;95(3):133-7.
From January 1st 1970 to December 31th 1985, 706 nephrectomies for renal cell carcinoma have been performed by the staff of the urologic clinic of the University of Erlangen-Nürnberg. 222 nephrectomies by lumbal and 484 by transabdominal incision. The following study compares the results of two groups of patients, who all have been operated transabdominally with curative goal (this means that there was no evidence for distant metastases). The two groups differ in the character of the associated lymph node dissection. The first group consists of patients on whom we performed a systematic lymph node dissection (LAS, n = 291). The second group consists of those patients on whome we performed a facultative lymp node dissection (LAF, n = 193). In this prospective study of postoperative survival rates, significantly better results are obtained in the LAS-group. The survival rates according to the stage of the tumor (Robson-classification) show that stage I and II profit most of the extended lymph node dissection. The bad prognosis for stage IIIa patients, determinated by tumor invasion into the renal vein, will not be changed after extended lymph node dissection. Patients with positive regional lymph nodes (stage IIIb + c) have a significantly better prognosis during the first three years after nephrectomy, obviously as the result of reduce tumor volume, but the benefit does not last over a longer period as 5 years. According to our results we are convinced that the systematically extended lymph node dissection is an important curative measure in the surgical therapy of renal cell carcinoma.
1970年1月1日至1985年12月31日期间,埃尔朗根 - 纽伦堡大学泌尿外科诊所的工作人员共为706例肾细胞癌患者实施了肾切除术。其中222例经腰部切口,484例经腹部切口。以下研究比较了两组均经腹部手术且以治愈为目的(即无远处转移证据)的患者的结果。两组在相关淋巴结清扫的特点上有所不同。第一组为我们对其进行了系统性淋巴结清扫的患者(LAS,n = 291)。第二组为我们对其进行了选择性淋巴结清扫的患者(LAF,n = 193)。在这项关于术后生存率的前瞻性研究中,LAS组取得了明显更好的结果。根据肿瘤分期(罗布森分期)的生存率显示,I期和II期患者从扩大的淋巴结清扫中获益最大。对于因肿瘤侵犯肾静脉而预后不良的IIIa期患者,扩大淋巴结清扫后预后并未改变。区域淋巴结阳性(IIIb + c期)的患者在肾切除术后的头三年预后明显较好,显然是肿瘤体积缩小的结果,但这种获益在5年以上的时间里并不持续。根据我们的结果,我们确信系统性扩大淋巴结清扫是肾细胞癌外科治疗中的一项重要治愈性措施。